-
Waiting for Surgery
Hello, I'm 48 and I was recently diagnosed with Invasive Lobular cancer of my left breast after a long journey. It started in December of 2023 when on a MRI they saw a spot that they wanted to recheck in six months. I was not super concerned as this had happened before on the right-hand side and it turned out to be…
-
Breast surgeon recommendation
Can anyone recommend some top surgical oncologists for breast cancer in the NYC area? I appreciate it in advance.
-
Triple-Negative Breast Cancer Treatment: Where Are We?
Triple-Negative Breast Cancer Treatment: Where Are We? Dr. Lisa Carey explains the latest research on TNBC treatments. Mar 7, 2025 About 10% to 15% of breast cancers are triple-negative. This means they don’t have receptors for the hormones estrogen or progesterone, and don’t have too many HER2 proteins. So, hormonal…
-
Single Hormone Status- IDC (ER+ PR- and Her2-) Newly Diagnosed
Hi! I am new here :) I was diagnosed 12/31/2024. So far I have had mammogram/US→ biopsies → diagnosed → MRI → results → Met with a Sugerical Oncologist → Currently waiting on oncotype results (from biopsy sample.) and I have a follow up with OS/Plastics this coming Monday. I have a large span of DCIS and 1.4cm IDC - both…
-
Join our webinar: Triple-Negative Breast Cancer Diagnosis and Treatment, March 25, 2025, 4:30pm ET
Triple-negative breast cancer (TNBC) is an invasive subtype of breast cancer that can be harder to treat and is more likely to come back. But there is hope for better therapies in the future, and support is available to help right now.Join us to learn about TNBC diagnosis and treatment from experts and patient advocates.…
-
FDA Approves Dato-DXd for advanced-stage HR+, HER2- breast cancer
-
Single Hormone Receptor Positive -> ER+/PR-/HER2-
Anyone else in this same boat? Would love input or sharing your experience. Feeling a little alone in this boat!
-
Delaying Chemotherapy for a Second Opinion
Hi- I'm just wondering if anyone on here has experienced the need to delay chemotherapy at any point in their journey. I was diagnosed back in Feb 2024, had my partial mastectomy with reconstruction bilaterally in April 2024 but developed a pretty bad infection due to an allergy to the blue dye they use when they inject…
-
Lynparza Approved To Treat High-Risk, Early-Stage, HER2-, BRCA+
Lynparza Approved To Treat High-Risk, Early-Stage, HER2-Negative Breast Cancer With BRCA Mutation Mar 13, 2022 The FDA approved Lynparza to treat early-stage, HER2-negative breast cancer with a BRCA1 or BRCA2 mutation and a high risk of recurrence, which also has been previously treated with chemotherapy — either before or…
-
Surgical Options
I was just diagnosed and am deciding between treatment options. I am already scheduled for surgery but now I am having doubts about the Lumpectomy and subsequent radiation therapy. In my honest opinion, I now feel that the mastectomy could be the better choice due to avoiding the radiotherapy and hormone therapy. Feeling…
-
Can Certain Younger Post-Menopausal Women With Low-Risk Breast Cancer Skip Radiation?
Can Certain Younger Post-Menopausal Women With Low-Risk Breast Cancer Skip Radiation? Dec 6, 2023 Research suggests that some younger post-menopausal women may be able to skip radiation after lumpectomy, but there are important points to consider. Read more…
-
Breast Cancer Vaccine Update
Breast Cancer Vaccine Update Dec 7, 2023 Dr. Justin Johnson explains early results from three small studies on a vaccine for triple-negative breast cancer. Dr. G. Thomas Budd, an oncologist, and Dr. Justin Johnson, an immunologist, are collaborating on research looking at a vaccine to prevent triple-negative breast cancer.…
-
Progression after ribociclib (csk4/6i) and letrozole
Hi I had her2 neg er+ breast cancer in 2018. In 2022 i had recurrence in my bones (all over with 3 collapsed vertebrae) and liver. I was on ribociclib and letrozole that worked really well, pet was negative and most metastasis disappear. In August I had liver recurrence. Blood test and markers are ok and i feel well so i…